Apogee Therapeutics Inc (APGE)
38.50 -0.96 (-2.43%) 14:12 ET [NASDAQ]
38.49 x 300 38.62 x 100
Realtime by (Cboe BZX)
38.49 x 300 38.62 x 100
Realtime - - (-) -
for Wed, Jan 22nd, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
Operating Expenses | 58,686 | 44,122 | 38,181 | 37,155 | 24,305 |
Operating Income | -58,686 | -44,122 | -38,181 | -37,155 | -24,305 |
Other Income | 9,668 | 10,306 | 6,087 | 5,420 | 3,465 |
Pre-tax Income | -49,018 | -33,816 | -32,094 | -31,735 | -20,840 |
Net Income Continuous | -49,018 | -33,816 | -32,094 | -31,735 | -20,840 |
Net Income | $-49,018 | $-33,816 | $-32,094 | $-31,735 | $-20,840 |
EPS Basic Total Ops | -0.86 | -0.60 | -0.64 | 3.44 | -0.51 |
EPS Basic Continuous Ops | -0.86 | -0.60 | -0.64 | 3.43 | -0.51 |
EPS Diluted Total Ops | -0.86 | -0.60 | -0.64 | 3.44 | -0.51 |
EPS Diluted Continuous Ops | -0.86 | -0.60 | -0.64 | 3.43 | -0.51 |
EPS Diluted Before Non-Recurring Items | N/A | -0.60 | -0.64 | -0.32 | -0.51 |
EBITDA(a) | $-62,143 | $-47,126 | $-40,862 | $-39,994 | $-24,305 |